DD296081A5 - Verfahren zur herstellung antibiotischer verbindungen - Google Patents

Verfahren zur herstellung antibiotischer verbindungen Download PDF

Info

Publication number
DD296081A5
DD296081A5 DD89338278A DD33827889A DD296081A5 DD 296081 A5 DD296081 A5 DD 296081A5 DD 89338278 A DD89338278 A DD 89338278A DD 33827889 A DD33827889 A DD 33827889A DD 296081 A5 DD296081 A5 DD 296081A5
Authority
DD
German Democratic Republic
Prior art keywords
compounds
solution
give
desxylosyl
xylosyl
Prior art date
Application number
DD89338278A
Other languages
German (de)
English (en)
Inventor
Nishio Maki
Kakushima Masatoshi
Konishi Masataka
Oki Toshikazu
Original Assignee
�������`�����@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������`�����@�������k�� filed Critical �������`�����@�������k��
Publication of DD296081A5 publication Critical patent/DD296081A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DD89338278A 1988-07-19 1989-07-18 Verfahren zur herstellung antibiotischer verbindungen DD296081A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/221,144 US4960755A (en) 1988-07-19 1988-07-19 BU-3608 derivatives

Publications (1)

Publication Number Publication Date
DD296081A5 true DD296081A5 (de) 1991-11-21

Family

ID=22826542

Family Applications (2)

Application Number Title Priority Date Filing Date
DD89338278A DD296081A5 (de) 1988-07-19 1989-07-18 Verfahren zur herstellung antibiotischer verbindungen
DD89330937A DD287509A5 (de) 1988-07-19 1989-07-18 Verfahren zur herstellung antibiotischer verbindungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD89330937A DD287509A5 (de) 1988-07-19 1989-07-18 Verfahren zur herstellung antibiotischer verbindungen

Country Status (23)

Country Link
US (1) US4960755A (pt)
EP (1) EP0351799B1 (pt)
JP (1) JP2772549B2 (pt)
KR (1) KR970003127B1 (pt)
AT (1) ATE100459T1 (pt)
AU (1) AU622197B2 (pt)
CA (1) CA1337907C (pt)
CS (1) CS274700B2 (pt)
DD (2) DD296081A5 (pt)
DE (1) DE68912438T2 (pt)
DK (1) DK170778B1 (pt)
ES (1) ES2048793T3 (pt)
FI (1) FI92206C (pt)
HU (2) HU203112B (pt)
IE (1) IE62586B1 (pt)
IL (1) IL91001A (pt)
MY (1) MY105128A (pt)
NO (1) NO170544C (pt)
NZ (1) NZ229964A (pt)
PT (1) PT91203B (pt)
RU (2) RU2032693C1 (pt)
YU (1) YU138289A (pt)
ZA (1) ZA895455B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114857A (en) * 1988-11-10 1992-05-19 Bristol-Myers Company Actinomadura hibisca microorganism useful for preparing serine analogs of BU-3608 antibiotics
US5183808A (en) * 1988-11-10 1993-02-02 Bristol-Myers Squibb Company Method for treating fungal infections with serine analogs of BU-3608 antibiotics
JP2643404B2 (ja) * 1989-01-13 1997-08-20 財団法人微生物化学研究会 新抗生物質ｎ―アセチルベナノマイシンｂならびにその製造法
US5098708A (en) * 1990-06-14 1992-03-24 Bristol-Myers Squibb Company Antiviral antibiotic BU-3889V
FI903460A0 (fi) * 1989-07-10 1990-07-09 Bristol Myers Squibb Co Antiviralt antibiotikum bu-3889v.
US5227370A (en) * 1989-11-14 1993-07-13 Bristol-Myers Squibb Company Pradimicin derivatives
FI92207C (fi) * 1989-11-14 1994-10-10 Squibb Bristol Myers Co Menetelmä terapeuttisesti käyttökelpoisten pradimisiinijohdannaisten valmistamiseksi
CA2030166C (en) * 1989-11-22 1997-10-07 Shimpei Aburaki Pradimicin derivatives
US5843908A (en) * 1990-09-28 1998-12-01 Bristol-Myers Squibb Company Pradimicins l and fl, and derivatives thereof
US5696096A (en) * 1990-09-28 1997-12-09 Bristol-Myers Squibb Company Pradimicin derivatives
US5326867A (en) * 1992-07-16 1994-07-05 Bristol-Myers Squibb Company Pradimic acids, amides, and pradimicin derivatives
US5338728A (en) * 1992-08-14 1994-08-16 Bristol-Myers Squibb Pradimicin compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591637A (en) * 1985-01-17 1986-05-27 Sri International Open chain-morpholino adriamycins
US4870165A (en) * 1987-02-02 1989-09-26 Bristol-Myers Company Antifungal antibiotics
JP2512050B2 (ja) * 1987-12-25 1996-07-03 財団法人微生物化学研究会 新規抗かび性抗生物質デキシロシルベナノマイシンｂならびにその製造法
US5055453A (en) * 1987-11-02 1991-10-08 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Benanomicins a and antibiotic compositions
US5696096A (en) * 1990-09-28 1997-12-09 Bristol-Myers Squibb Company Pradimicin derivatives

Also Published As

Publication number Publication date
DK354689A (da) 1990-01-20
DD287509A5 (de) 1991-02-28
YU138289A (en) 1991-02-28
KR900001715A (ko) 1990-02-27
KR970003127B1 (ko) 1997-03-14
HU908256D0 (en) 1991-06-28
IE62586B1 (en) 1995-02-08
DE68912438D1 (de) 1994-03-03
PT91203A (pt) 1990-02-08
EP0351799B1 (en) 1994-01-19
FI92206B (fi) 1994-06-30
CS440889A2 (en) 1990-11-14
NO170544B (no) 1992-07-20
ES2048793T3 (es) 1994-04-01
NO170544C (no) 1992-10-28
AU622197B2 (en) 1992-04-02
RU2026302C1 (ru) 1995-01-09
ATE100459T1 (de) 1994-02-15
FI92206C (fi) 1994-10-10
JP2772549B2 (ja) 1998-07-02
RU2032693C1 (ru) 1995-04-10
NZ229964A (en) 1991-07-26
EP0351799A2 (en) 1990-01-24
PT91203B (pt) 1995-03-01
IE892325L (en) 1990-01-19
US4960755A (en) 1990-10-02
DK170778B1 (da) 1996-01-15
AU3827489A (en) 1990-01-25
DK354689D0 (da) 1989-07-18
ZA895455B (en) 1991-12-24
IL91001A (en) 1995-06-29
CA1337907C (en) 1996-01-09
JPH0273095A (ja) 1990-03-13
CS274700B2 (en) 1991-09-15
EP0351799A3 (en) 1991-04-24
HU203112B (en) 1991-05-28
NO892939L (no) 1990-01-22
HU205131B (en) 1992-03-30
HUT51283A (en) 1990-04-28
FI893426A (fi) 1990-01-20
MY105128A (en) 1994-08-30
DE68912438T2 (de) 1994-06-01
FI893426A0 (fi) 1989-07-14
IL91001A0 (en) 1990-02-09
NO892939D0 (no) 1989-07-18

Similar Documents

Publication Publication Date Title
DE69125963T2 (de) R106-Verbindungen
CH638194A5 (de) Esterastin, eine neue physiologisch wirksame substanz und deren herstellung.
DE3887820T2 (de) Antibiotika, Benanomicine A und B und Dexylosylbenanomicin B, ihre Herstellung und Verwendung.
DE68909170T2 (de) Serin-Analoge von BU-3608-Antibiotika.
EP0013766B1 (de) Antibiotica, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pflanzenschutzmittel
DD296081A5 (de) Verfahren zur herstellung antibiotischer verbindungen
CH630957A5 (de) Verfahren zur herstellung von neuen antibiotischen verbindungen auf basis eines bohemsaeurekomplexes.
DE3881576T2 (de) Anthracyclinderivate und ihre Verwendung.
DE68906825T2 (de) Glycosid-Antibiotika BU-3608D und BU-3608E.
DE68920898T2 (de) Aglykone von A/16686-Antibiotika.
DE3634496C2 (de) Glukosylmoranolinderivate und ihre Herstellung
DE2326916C2 (de) Anhydro-4-carbamoyl-5-hydroxy-1-ribofuranosylimidazoliumhydroxyd
CH640868A5 (de) 3-0-(beta-d-glucoronpyranosyl)-sojasapogenol b, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
DE2917000C2 (de) 1β-(6-Amino-9H-purin-9-yl)-4-hydroxymethyl-4-cyclopenten-2α,3α-diol (Neplanocin A), Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
DE69903465T2 (de) Vancoresmycin, verfahren zu dessen herstellung und dessen anwendung als arzneimittel
DE2900315C2 (de) 3"-N-Methyl-4"-C-methyl-3',4'-didesoxy-kanamycine oder deren 4"-Epimere, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE69127935T2 (de) Antibiotikum Balmimycin, dessen Verfahren zur Herstellung und dessen Verwendung als Arznei
DE2803681C2 (pt)
DE3887292T2 (de) Antibiotische Verbindungen, genannt A/16686-Faktoren A'1,A'2 und A'3.
DE69004808T2 (de) Antibiotikum N-Acetylbenanomicin B, dessen Herstellung und Verwendung.
DE69711506T2 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
EP0173948A2 (de) Neue Pseudooligosaccharide mit alpha-Glukosidase-hemmender Wirkung, Verfahren zur deren Herstellung, deren Verwendung und pharmazeutische Präparate
DE60132703T2 (de) Citrullimycine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69419083T2 (de) Salmycine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3425357A1 (de) 1-hydroxy-cytorhodine, ein mikrobiologisches verfahren zu ihrer herstellung und ihre verwendung als cytostatika

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20090719